Atai stocks.

Company Description. ATAI Life Sciences N.V., a clinical-stage biopharmaceutical company, engages in acquiring, incubating, and developing various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. Its principal clinical programs include RL-007, a pro-cognitive neuromodulator for cognitive …Find the latest Atari SA (ALATA.PA) stock quote, history, news and other vital information to help you with your stock trading and investing.See Full ATAI Report. ATAI stock closed at $1.12 and is down -$0.08 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. ATAI has a poor overall score of 33 meaning the stock holds a better value than just 33% of stocks at its current price.WebTipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.com

Funding. ATAI Life Sciences has raised a total of. $522.1M. in funding over 11 rounds. Their latest funding was raised on Aug 15, 2022 from a Post-IPO Debt round. ATAI Life Sciences is registered under the ticker NASDAQ:ATAI . Their stock opened with $15.00 in its Jun 17, 2021 IPO. ATAI Life Sciences is funded by 42 investors.WebOverview News Ideas Financials Technicals Forecast ATAI chart Today 7.69% 5 days 3.70% 1 month −10.40% 6 months −35.26% Year to date −58.67% 1 year −68.27% 5 …Sep 9, 2022 · Math Over Myth aims to remove the romance and mythology from investing to focus strictly on price movements, mathematics, and technical analysis. Today we focus on ATAI and CMPS. Investing in emerging, disruptive, and speculative sectors of the marketplace doesn’t necessarily need to be a risky endeavor if you approach it with the right ...

According to our current ATAI stock forecast, the value of Atai Life Sciences N.V. shares will drop by -18.90% and reach $ 0.875911 per share by December 3, 2023. According to our technical indicators, the current sentiment is Bearish while the Fear & Greed Index is showing 39 (Fear).ATAI stock recorded 10/30 (33%) green days with 6.79% price …

On December 2, 2023, the Board appointed Sahil Kirpekar, M.D. and Ryan Barrett as the new atai Board designees pursuant to the Rights Agreement, to serve until …Apr 12, 2023 · ATAI Life Sciences NV ( ATAI) is up Wednesday morning, with the stock gaining 1.12% in pre-market trading to 1.8. ATAI's short-term technical score of 12 indicates that the stock has traded less bullishly over the last month than 88% of stocks on the market. In the Biotechnology industry, which ranks 115 out of 146 industries, ATAI ranks higher ... If you want to skip our detailed analysis of these stocks, go directly to the 5 Best Psychedelic Stocks to Buy Now. ... CMPS), Atai Life Sciences N.V. (NASDAQ: ATAI), and Seelos Therapeutics, Inc ...ATAI Stock Price | ATAI Life Sciences N.V. Stock Quote (U.S ...

ATAI Life Sciences N.V. analyst ratings, historical stock prices, earnings estimates & actuals. ATAI updated stock price target summary.

Open Int (30-Day): The average total open interest for all option contracts (across all expiration dates) for the last 30 days. Atai Life Sciences N.V. stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.

ATARI : AVAILABILITY OF THE 2023 UNIVERSAL REGISTRATION DOCUMENT. 01/08/2023. ATARI: FY2023 ANNUAL RESULTS. Stock ATARI S.A. Common Stock FR0010478248 ALXP Euronext Growth Paris Live Euronext quotes, realtime prices, charts and regulated news.WebCreso Pharma and Red Light Holland entered into a definitive scheme implementation deed to combine businesses and create The HighBrid LabATAI is down -$0.02 from the previous closing price of $1.14 on volume of 308,405 shares. Over the past year the S&P 500 has risen 15.21% while ATAI is down -62.79%. ATAI lost -$0.46 per share in the over the last 12 months. ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health ...After all, if you look at the year-over-year performance of most psychedelic stocks, you’ll see naught but carnage. For example, Compass Pathways (Nasdaq: CMPS) has collapsed 62% over the last year, atai Life Sciences (Nasdaq: ATAI) has crashed 74%, and MindMed (Nasdaq: MNMD, NEO: MMED) has plummeted a horrifying 90%.WebThe Atai Life Sciences N.V. stock forecast for tomorrow is $ 1.095019, which would represent a -2.23% loss compared to the current price. In the next week, the ...atai’s development candidates, such as RL-007 and GRX-917, all represent significant opportunities to address unmet medical needs of patients living with mental health conditionsContinued ...

Open a brokerage account and deposit funds in it to purchase stock in a company, explains the Wall Street Journal. Companies such as Charles Schwab, E-Trade, and Ameritrade provide brokerage services.Under a securities purchase agreement, atai has agreed to purchase 37,300,000 shares of common stock of the Corporation (the “Shares”) and 22,380,000 warrants (the “Warrants”) for ...ATAI Life Sciences (NASDAQ: ATAI) is another clinical-stage biotech looking to make a mark in the mental health space. Its stock took a dive recently following failed results of its Phase 2a study ...Dividends on stock: dividend pay date calendar, dividend per share, dividend payment, dividend historical data, dividend policy, dividend news, ... Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates …Web17atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders and was founded as a response to the significant unmet need and lack of innovation ...Fundamentals ATAI LIFE SCIENCES BV EO1. Dividend. Dividend yield in %. P/E Ratio, -1.17. Profit per share, -0.84. Number of shares, 165.94 m. Market ...

Nov 30, 2023 · ATAI Life Sciences NV’s trailing 12-month revenue is $0.3 million with a % profit margin. Year-over-year quarterly sales growth most recently was %. Analysts expect adjusted earnings to reach $-0.317 per share for the current fiscal year. ATAI Life Sciences NV does not currently pay a dividend.

atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders and was founded as a response to the significant unmet need and lack of innovation ...ATAI Life Sciences NV’s trailing 12-month revenue is $0.3 million with a % profit margin. Year-over-year quarterly sales growth most recently was %. Analysts expect adjusted earnings to reach $-0.317 per share for the current fiscal year. ATAI Life Sciences NV does not currently pay a dividend.The Atai Life Sciences N.V. stock forecast for tomorrow is $ 1.055893, which would represent a -2.23% loss compared to the current price. In the next week, the price of ATAI is expected to decrease by -18.90% and hit $ 0.875911. As far as the long-term Atai Life Sciences N.V. stock forecast is ...The latest price target for ATAI Life Sciences (NASDAQ: ATAI) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price ...Find the latest Atari SA (ALATA.PA) stock quote, history, news and other vital information to help you with your stock trading and investing.Jan 8, 2023 · What makes a psychedelic company compelling? Analyst Alex Carchidi has a background in biotech and focuses on long-term growth and risk management. Pros and cons to owning his top 5 stocks. Feb 9, 2023 · 1. ATAI Life Sciences. The financial services firm H.C. Wainwright & Co. recently issued a $20 price target on ATAI Life Sciences (NASDAQ: ATAI) stock. This 12-month price target implies an upside ...

A high-level overview of Atari SA (PONGF) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

The upgrade of atai Life Sciences N.V. to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the ...

Get the latest Atai Life Sciences N.V. (ATAI) stock news and headlines to help you in your trading and investing decisions.atai Life Sciences - ATAI - Stock Price Today - Zacks atai Life Sciences (ATAI) (Delayed Data from NSDQ) $1.09 USD +0.02 (1.87%) Updated Nov 22, 2023 …atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders and was founded as a response to the significant unmet need and lack of innovation ...Atai Life Sciences (NASDAQ: ATAI) is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. In the first week of the new year, the stock plummeted when the failed results of ATAI's NYC-based subsidiary, Perception Neuroscience's Phase 2a study of proprietary R-ketamine PCN-101 on patients with ...$0.08 (7.69%) Today $1.14 0.02 (1.79%) After Hours About Feed News Earnings Fundamentals There is no chart data available for this period 1d 1w 1m 3m 6m 1y All …On January 6, Atai announced that a highly anticipated trial of a ketamine-based depression treatment failed to meet its goals. The news sent Atai's stock tumbling by about a third, deepening the ...ATAI Life Sciences NV (ATAI) stock is trading at $1.66 as of 3:26 PM on Monday, Feb 27, a rise of $0.04, or 2.47% from the previous closing price of $1.62. The stock has traded between $1.63 and $1.70 so far today. Volume today is below average. So far 623,184 shares have traded compared to average volume of 1,308,129 shares. Click Here to get ...Stock Price & Overview 3.84K followers $1.07 -0.05 ( -4.46%) 4:00 PM 11/21/23 NASDAQ | $USD | Post-Market: $1.11 +0.04 (+3.74%) 7:59 PM Summary Ratings Financials …Atai Capital experienced a decline of 5.8% in the third quarter, bringing our year-to-date (YTD) returns to 6.5% net of all fees. This compares to a 13.1% total return for the S&P 500 YTD and a 2. ...ATAI Life Sciences N.V. Common Shares (ATAI) 0 Add to Watchlist Add to Portfolio Quotes Summary Real-Time After-Hours Live Key Data Bid Price and Ask Price The bid & ask refers to the price...

Dec 1, 2023 · View atai Life Sciences NV ATAI investment & stock information. Get the latest atai Life Sciences NV ATAI detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Even in a speculative industry, I believe the stock is undervalued by these few facts alone. ATAI holds: 450M cash and cash equivalents; 20% equity stake in CMPS (750M mktcp - 150M worth at current prices); and ATAI has a vast ip pipeline that includes 9 lead compounds. Curious as to the community’s thoughts here!Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.Instagram:https://instagram. crcwishares tltforex trading booksford motor company dividend history atai Life Sciences N.V. - Buy. Zacks' proprietary data indicates that atai Life Sciences N.V. is currently rated as a Zacks Rank 2 and we are expecting an above average return from the ATAI shares ...Oct 24, 2023 · Mind Medicine Inc. ( MNMD) MindMed shares are down by 38.7% over the past three months, but they are up 23.2% year to date as of Oct. 24. The New York-based company specializes in the development ... honda electric riding lawn mowervalue of 1921 silver dollars Atai Capital highlighted stocks like Alphabet Inc. (NASDAQ:GOOG) in the Q3 2023 investor letter. Headquartered in Mountain View, California, Alphabet Inc. (NASDAQ:GOOG) is a multinational ...ATAI Life Sciences N.V. analyst estimates, including ATAI earnings per share estimates and analyst recommendations. starlink el salvador Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.Stock Symbol; ATAI; Investments; 19; Share Price; $1.09 (As of Wednesday Closing) ATAI Life Sciences General Information. Description. ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL ...